Results

Total Results: 186 records

Showing results for "reasons".

141. Healthcare Expenditures for Heart Disease among Adults Aged 18 and Older in the U.S. Civilian Noninstitutionalized Population, 2022
     meps.ahrq.gov/data_files/publications/st562/stat562.shtml
     July 01, 2025 - Healthcare Expenditures for Heart Disease among Adults Aged 18 and Older in the U.S. Civilian Noninstitutionalized Population, 2022   Skip to main content An official website of the Department of Health & Human Services …

142. RESEARCH FINDINGS #49: Pre-COVID-19 Retail Use and Expenditures for Drugs That Were Subsequently Used to Treat COVID-19
     meps.ahrq.gov/data_files/publications/rf49/rf49.shtml
     July 01, 2021 - Some COVID-19-relevant medications were not included in this report for one or more of the following reasons

143. Healthcare Use and Expenditures for COVID-19, U.S. Civilian Noninstitutionalized Population, 2020
     meps.ahrq.gov/data_files/publications/st549/stat549.shtml
     July 01, 2023 - and prescribed medicine purchases, we do not report estimates for these event types for the following reasons

144. Methodology Report #36: Analyzing Medical Conditions in MEPS - Detailed Reference (Part 2 of 2)
     meps.ahrq.gov/data_files/publications/mr36/mr36dr.shtml
     February 24, 2023 - MEPS estimates might not benchmark to other sources due to several reasons: Survey population

145. Any Use and "Frequent Use" of Opioids among Elderly Adults in 2018-2019, by Socioeconomic Characteristics
     meps.ahrq.gov/data_files/publications/st550/stat550.shtml
     September 01, 2023 - Any Use and "Frequent Use" of Opioids among Elderly Adults in 2018-2019, by Socioeconomic Characteristics   Skip to main content An official website of the Department of Health & Human Services …

146. Pre-COVID-19 Retail Use and Expenditures for Drugs That Were Subsequently Used to Treat COVID-19 (pdf file)
     meps.ahrq.gov/data_files/publications/rf49/rf49.pdf
     December 04, 2020 - Some COVID-19-relevant medications were not included in this report for one or more of the following reasons

147. Research Findings #44: Retail Drug Prices, Out-of-Pocket Costs, and Discounts and Markups Relative to List Prices: Trends and Differences by Drug Type and Insurance Status, 2011 to 2016 (pdf file)
     meps.ahrq.gov/data_files/publications/rf44/rf44.pdf
     October 01, 2019 - This is not surprising for two reasons: First, older generic drugs tend to have a large spread between

148. MEPS - IC Technical Notes
     meps.ahrq.gov/survey_comp/ic_technical_notes.shtml
     January 01, 2020 - The two most common reasons for funding larger State samples are

149. Chartbook #10: Changes in Job-related Health Insurance, 1996-99
     meps.ahrq.gov/data_files/publications/cb10/cb10.shtml
     June 01, 2002 - Even among establishments with similar characteristics, premiums can vary for a number of reasons, including

150. Chartbook #9: The Uninsured in America, 1996-2000
     meps.ahrq.gov/data_files/publications/cb9/cb9.shtml
     June 01, 2002 - For a detailed explanation of possible reasons for differences among survey estimates, see "Understanding

151. Methodology Report #30: Sample Design of the 2014 Medical Expenditure Panel Survey Insurance Component (pdf file)
     meps.ahrq.gov/data_files/publications/mr30/mr30.pdf
     June 01, 2015 -  Charges, payments, and the reasons for any difference between charges and payments.

152. Chartbook #12: Outpatient Prescription Drug Expenses, 1999
     meps.ahrq.gov/data_files/publications/cb12/cb12.shtml
     April 01, 2001 - Use and expenses for prescription drugs vary across subgroups of the community population for many reasons

153. Chartbook #11: Health Care Expenses in the Community Population, 1999
     meps.ahrq.gov/data_files/publications/cb11/cb11.shtml
     October 01, 2003 - The main reasons for the differences are that the NHA include a wider variety of expenses and also include

154. Methodology Report #31: Sample Design of the 2017 Medical Expenditure Panel Survey Insurance Component
     meps.ahrq.gov/data_files/publications/mr31/mr31.shtml
     July 01, 2018 - Charges, payments, and the reasons for any difference between charges and payments.

155. Methodology Report #30: Sample Design of the 2014 Medical Expenditure Panel Survey Insurance Component
     meps.ahrq.gov/data_files/publications/mr30/mr30.shtml
     June 01, 2015 - Charges, payments, and the reasons for any difference between charges and payments.

156. Methodology Report #27: Sample Design of the 2011 Medical Expenditure Panel Survey Insurance Component
     meps.ahrq.gov/data_files/publications/mr27/mr27.shtml
     March 01, 2013 - §   Charges, payments, and the reasons for any difference between charges and payments.

157. Methodology Report #27: Sample Design of the 2011 Medical Expenditure Panel Survey Insurance Component (pdf file)
     meps.ahrq.gov/data_files/publications/mr27/mr27.pdf
     March 01, 2013 -  Charges, payments, and the reasons for any difference between charges and payments.

158. Research Findings #23: Trends in Children's Antibiotic Use: 1996 to 2001
     meps.ahrq.gov/data_files/publications/rf23/rf23.shtml
     March 01, 2005 - These condition-specific trends are of interest for several reasons.

159. MEPS HC-051B: 2000 Dental Visits
     meps.ahrq.gov/data_stats/download_data/pufs/h51b/h51bdoc.shtml
     February 01, 2003 - This could occur for several reasons including (1) free care was provided, (2) bad debt was incurred,

160. Methodology Report #12: Outpatient Prescription Drugs: Data Collection and Editing in the 1996 Medical Expenditure Survey (HC-010A) (pdf file)
     meps.ahrq.gov/data_files/publications/mr12/mr12.pdf
     June 01, 2001 - • Charges, payments, and the reasons for any difference between charges and payments. … For these reasons, it became necessary to impute NDC values to these 12,870 records.